Last updated on

New England Journal of Medicine
Research Hotspot & Journal Scope - Patients


New England Journal of Medicine - DOI: 10.1056/NEJMc1903982
Transcatheter Mitral-Valve Repair in Patients with Heart Failure.

Dimitri Kalavrouziotis · Pierre Voisine · Siamak Mohammadi ·

Medicine
PDF
New England Journal of Medicine - DOI: 10.1056/NEJMOA1814630
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.

Cassini Investigators ·

Medicine
PDF
New England Journal of Medicine - DOI: 10.1056/NEJMoa1815281
Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions.

Kirsten Fischer · Othman Al-Sawaf · Jasmin Bahlo · Anna-Maria Fink · Maneesh Tandon · Mark Dixon · Sandra Robrecht · Simon Warburton · Kathryn Humphrey · Olga Samoylova · Anna M Liberati · Javier Pinilla-Ibarz · Stephen Opat · Liliya Sivcheva · Katell Le Dû · Laura M Fogliatto · Carsten U Niemann · Robert Weinkove · Sue Robinson · Thomas J Kipps · Sebastian Boettcher · Eugen Tausch · Rod Humerickhouse · Barbara Eichhorst · Clemens-Martin Wendtner · Anton W Langerak · Karl-Anton Kreuzer · Matthias Ritgen · Valentin Goede · Stephan Stilgenbauer · Mehrdad Mobasher · Michael Hallek ·

Medicine
PDF
New England Journal of Medicine - DOI: 10.1056/nejmoa1908419
Ticagrelor with or without Aspirin in High-Risk Patients after PCI.

Roxana Mehran · Usman Baber · Samin K Sharma · David J Cohen · Dominick J Angiolillo · Carlo Briguori · Jin Y Cha · Timothy Collier · George Dangas · Dariusz Dudek · Vladimír Džavík · Javier Escaned · Robert Gil · Paul Gurbel · Christian W Hamm · Timothy Henry · Kurt Huber · Adnan Kastrati · Upendra Kaul · Ran Kornowski · Mitchell Krucoff · Vijay Kunadian · Steven O Marx · Shamir R Mehta · David Moliterno · E Magnus Ohman · Keith Oldroyd · Gennaro Sardella · Samantha Sartori · Richard Shlofmitz · P Gabriel Steg · Giora Weisz · Bernhard Witzenbichler · Ya-Ling Han · Stuart Pocock · C Michael Gibson ·

Medicine
PDF
New England Journal of Medicine - DOI: 10.1056/NEJMoa1901118
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

Mansoor Husain · Andreas L Birkenfeld · Morten Donsmark · Kathleen Dungan · Freddy G Eliaschewitz · Denise R Franco · Ole K Jeppesen · Ildiko Lingvay · Ofri Mosenzon · Sue D Pedersen · Cees J Tack · Mette Thomsen · Tina Vilsbøll · Mark L Warren · Stephen C Bain ·

Medicine
PDF

RESULTS A total of 80 post-PCI patients were recruited and randomly divided into two equal groups.

Innovative Application of a Home-Based and Remote Sensing Cardiac Rehabilitation Protocol in Chinese Patients After Percutaneous Coronary Intervention. [10.1089/tmj.2018.0064]


These findings provide a good basis in directing us a step further to discover better novel treatment modalities to treat millions of HIV-1 patients.

Designed antiviral ankyrin – A computational approach to combat HIV-1 via intracellular pathway by targeting the viral capsid of HIV-1 [10.1016/J.MOLLIQ.2018.12.030]


METHODS Hematoxylin and eosin stained slides from 211 DCIS patients were reviewed.

Stromal characteristics are adequate prognosticators for recurrence risk in ductal carcinoma in situ of the breast. [10.1016/j.ejso.2018.11.005]


194 patients had one or more amylase result above normal range (100 U/L), with 9 patients between 209 and 299 U/L, and 6 patients greater than 300 U/L.

PWE-074 Amylase testing in primary care – does it identify pathology? [10.1136/gutjnl-2019-BSGAbstracts.305]


Recent evidence demonstrated that weekly prophylaxis with subcutaneous bispecific antibody (emicizumab) has shown higher efficacy in adolescent and adults patients affected by haemophilia A (HA) with inhibitor, compared with patients treated on demand or on prophylaxis with bypassing agents (BPAs).

Cost-Effectiveness and Budget Impact of Emicizumab Prophylaxis in Haemophilia A Patients with Inhibitors. [10.1055/s-0039-3401822]


Highly Related Keywords from Patients

Research Hotspot

New England Journal of Medicine

Research Hotspot
New England Journal of Medicine Related Journals

Popular Journals